Understanding the health of women and babies
The evidence to drive informed decisions about pregnancy and maternal and infant health is difficult to acquire. Linking maternal exposures to infant health outcomes is even more complicated.
Optum Epidemiology developed a valuable resource to provide evidence to help better understand the patients who will ultimately use your products: Optum® Dynamic Assessment of Pregnancies and Infants (Optum DAPI).
A broader view of maternal and infant health
Optum DAPI links a variety of woman and infant variables, such as:
- Demographics
- Maternal comorbidities
- Pregnancy detail, health care utilization
- Pregnancy, infant outcomes
- Infant health care utilization
We also have the potential to link electronic health record (EHR) data.
Related content

When ‘Is it safe for me?’ changes to ‘Is it safe for us?’
Studying the impact of treatments on pregnancy and infants can help patients, providers and pharmaceutical companies make key decisions.

Optum Dynamic Assessment of Pregnancies and Infants
Assess the impact of medication use during pregnancy and the impact on infant health.

Is Your Real-World Data Research Ready?
Real-world data can help evaluate the effectiveness of medications and therapies, which is why evaluation should be part of the investment.
Top